ArticleCancer chemotherapy and pharmacology2026
Homoharringtonine suppresses gastric cancer progression by targeting PI3K/ AKT/FOXO pathway and impairing the GSH-GPX4 antioxidant axis.
Xiaonan Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.